Metavia Inc share price logo

Metavia Inc Share Price

NASDAQ: MTVA

Small Cap

$0.70

+0.04

(+6.73%)

as on

Metavia Inc Stock Performance

as on November 15, 2025 at 2:29 am IST

  • Day's Low

    $0.62
    $0.7
    downward going graph

    11.43%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.56
    $2.75
    downward going graph

    20.64%

    Downside

    292.86%

    Upside

    downward going graph

Metavia Inc share price movements today

Previous Close
$0.66
Open
$0.62
Volume
397.3K
Day's Low - High
$0.62 - $0.7
52 Week Low - High
$0.56 - $2.75

Metavia Inc Historical Returns

1 Month Return
-35.29 %
3 Month Return
+ 3.13 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Metavia Inc Stock Fundamentals & Key Indicators

Check Metavia Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.1M

EPS (TTM)

-1.0625

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-168.18%

Metavia Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metavia Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Metavia Inc image
Metavia Inc
NA$17.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$59.8B235.01%1414.811.36%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$40.9BNA712.211.38%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.2B92.67%30.5831.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$71.6B22.7%16.3432.13%

Metavia Inc Stock’s Investor Sentiment and Interest

Search interest for Metavia Inc Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:63% versus previous 30 day period

Metavia Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
Operating Income
-3
-5
-6
-10
-6
-5
-3
-4
-3
EBITDA
-3
-2
-6
-10
-6
-5
-3
-3
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-5
-6
-10
-5
-5
-3
-3
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-3
-5
-6
-10
-5
-5
-3
-3
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Metavia Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-29
-15
-19
-15
-28
EBITDA
-29
-15
-11
-15
-28
Interest Expense
-
-
2
-
-
Depreciation
0
0
0
0
0
Income Before Tax
-29
-15
-13
-12
-27
Income Tax Expense
-
-
-
-
-
Net Income
-29
-15
-13
-12
-27
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Metavia Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-3
-5
-6
-10
-5
-5
-3
-3
-3
Operating Cash Flow
-2
-3
-6
-7
-5
-5
-4
-3
-2
Investing Cash Flow
0
0
0
0
-
-
-
0
-
Financing Cash Flow
-
-
-
19
0
0
0
9
0
Change in Cash
-2
-3
-6
11
-6
-5
-4
6
-3

Metavia Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-33
-15
-21
-29
-15
-13
-12
-27
Operating Cash Flow
-11
-26
-14
-7
-10
-15
-11
-10
-24
Investing Cash Flow
-
-
0
-6
0
0
0
0
0
Financing Cash Flow
31
21
17
24
6
22
28
0
18
Change in Cash
20
-5
2
11
-3
6
16
-10
-6

Insights on Metavia Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 81.5% return, outperforming this stock by 175.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 90.6% return, outperforming this stock by 163.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MTVA stock has moved down by -27.3%

About Metavia Inc

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. It is developing DA-1726 for the treatment of obesity and is developing DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes. Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide 1, glucagon-dependent insulinotropic polypeptide receptor, and peptide YY.
OrganisationMetavia Inc
Headquarters545 Concord Avenue, Cambridge, MA, United States, 02138
CEOMr. Heon Kim Hyung
E-voting on sharesClick here to vote

Key Management of Metavia Inc

Name

Title

Mr. Marshall H. Woodworth

Chief Financial Officer

Dr. Mi-Kyung Kim

Chief Scientific Officer

Mr. Robert Homolka

Senior Vice President of Clinical Operations

Dr. W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Mr. Michael C. Pine

Senior Vice President of Business Development Advisor

Mr. Heon Kim Hyung

CEO, President & Director

FAQs

What is Metavia Inc share price today?

Metavia Inc share price today is $0.7 as on at the close of the market. Metavia Inc share today touched a day high of $0.7 and a low of $0.62.

What is the 52 week high and 52 week low for Metavia Inc share?

Metavia Inc share touched a 52 week high of $2.75 on and a 52 week low of $0.56 on . Metavia Inc stock price today i.e. is closed at $0.7,which is 74.55% down from its 52 week high and 26.01% up from its 52 week low.

What is Metavia Inc's market capitalisation today?

Metavia Inc market capitalisation is $0.00T as on .

How to invest in Metavia Inc Stock (MTVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Metavia Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metavia Inc Shares that will get you 2.1429 shares as per Metavia Inc share price of $0.7 per share as on November 15, 2025 at 2:29 am IST.

What is the minimum amount required to buy Metavia Inc Stock (MTVA) from India?

Indian investors can start investing in Metavia Inc (MTVA) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Metavia Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Metavia Inc share’s latest price of $0.7 as on November 15, 2025 at 2:29 am IST, you will get 14.2857 shares of Metavia Inc. Learn more about fractional shares .